BSECorp. Action9h ago · 27 Oct 2026, 04:39 pm
Attached
Dr. Lal PathLabs Ltd · 539524
✦ AI SummaryDividend
Dr. Lal PathLabs Ltd has announced that its Board of Directors will consider a 2nd Interim Dividend for the Financial Year 2026-27 at its meeting on November 04, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Lal PathLabs Ltd - 539524 - Corporate Action-Board to consider Dividend
Attachments (1)
📄pdf
Download →
1527b875-ace6-4820-a1ea-be235b77ac11.pdf
View document text
October 27, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Corporate Relationship Department
Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers
Bandra Kurla Complex, Bandra (E) Dalal Street
Mumbai – 400 051 Mumbai – 400 001
Symbol: LALPATHLAB Scrip Code: 539524
Sub: Consideration of 2nd Interim Dividend, if any for the Financial Year 2026-27
Ref: Intimation of Board Meeting dated September 25, 2026
Dear Sir/ Madam,
This is in continuation of our earlier intimation dated September 25, 2026, with respect to
Intimation of Board Meeting scheduled to be held on Wednesday, November 04, 2026,
to inter-alia consider and approve the un-audited (Standalone & Consolidated) Financial
Results of the Company for the Quarter and Half Year ended on September 30, 2026.
We would like to further inform you that the Board of Directors at the same meeting
scheduled for November 04, 2026, shall also consider 2nd Interim Dividend, if any, on the
Equity Shares of the Company for the Financial Year 2026-27.
We request you to kindly take the same on record.
Thanking You,
Yours Faithfully,
For Dr. Lal PathLabs Limited
Vinay Gujral
Company Secretary & Compliance Officer